Diabetes insipidus in infants and children

Area of Science:

• Pediatric Endocrinology
• Nephrology
• Internal Medicine

Background:

• Diabetes insipidus (DI) is characterized by the inability to concentrate urine, leading to polyuria and polydipsia.
• Central DI (CDI), due to vasopressin deficiency, is more prevalent in children than nephrogenic DI (NDI), which involves impaired vasopressin response.
• Management of DI in pediatric patients presents distinct challenges compared to adults.

Purpose of the Study:

• To outline the unique manifestations and management considerations of diabetes insipidus in infants and children.
• To highlight the specific challenges in pediatric DI, including infant caloric needs and medication titration in growing individuals.
• To review standard and specialized treatment modalities for pediatric DI.

Main Methods:

• Review of existing literature on pediatric diabetes insipidus.
• Analysis of treatment strategies including vasopressin and thiazide diuretics.
• Discussion of special considerations for managing pediatric DI in specific patient populations.

Main Results:

• Central DI is more common in children than nephrogenic DI.
• Infant feeding requirements and medication dose adjustments for growth pose unique management challenges.
• Treatment aims to reduce urine output and thirst, ensuring fluid balance and quality of life.

Conclusions:

• Pediatric diabetes insipidus management necessitates individualized strategies addressing age-specific physiological needs.
• Therapeutic approaches involve vasopressin analogs or thiazide diuretics, with careful monitoring.
• Special populations, including adipsic, post-surgical, or chemotherapy patients, require tailored management plans.